Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

App Helps Improve Cubis Balance

By Drug Discovery Trends Editor | May 31, 2013

Sartorius, a leading international supplier for the pharmaceutical and laboratory industry, has made its premium laboratory balance Cubis even more user-friendly to ensure reliable, error-free results. Sartorius Q-Apps can now be installed on any Cubis balance to guide users quickly and easily in performing any weighing application.

The Q-Apps are available for weighing applications that are frequently performed, such as determination of the minimum sample weight according to the USP, differential weighing, formula or recipe management, average weight control – i.e., checking the net content of packages – application-specific calibration, or easy pipette calibration. Once downloaded, they can be selected from the balance’s task list. Each application will guide the user step by step through the weighing process selected. Q-Apps ensure 100 percent compliance with SOPs (standard operating procedures) that specify workflow instructions and analytical methods. This eliminates the need for additional checking of weighing results, saving valuable time and money in the laboratory.

Customized Q-Apps have been developed to meet special requirements that differ from standardized weighing processes. These are individually tailored to the customer’s specific requirements and implement the work instructions and analytical procedures exactly as described in the customer’s SOP. Therefore, the Cubis balance “adapts” in order to meet the customer’s requirements 100 percent – and not the other way around. As a result, customized Q-Apps turn a standard Cubis balance into a “Cubis individual” version.

Q-Apps can be downloaded from the Sartorius AppCenter at www.sartorius.com/cubisindividual and directly installed on Cubis using an SD card. The Q-App software can be tested for 30 days free of charge before it must be licensed for a fee. Moreover, Q-Apps enable the balance to exchange data with a higher-level laboratory management system via Web services. This interface protocol is Internet-based, recognized and qualified. As a result, a Cubis balance can be quickly and easily connected to a laboratory management system. This minimizes the time and effort entailed by manual documentation in the lab.

Sartorius


Filed Under: Drug Discovery

 

Related Articles Read More >

EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE